These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
287 related articles for article (PubMed ID: 7731155)
1. Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. The Iohexol Cooperative Study. Rudnick MR; Goldfarb S; Wexler L; Ludbrook PA; Murphy MJ; Halpern EF; Hill JA; Winniford M; Cohen MB; VanFossen DB Kidney Int; 1995 Jan; 47(1):254-61. PubMed ID: 7731155 [TBL] [Abstract][Full Text] [Related]
2. Multicenter trial of ionic versus nonionic contrast media for cardiac angiography. The Iohexol Cooperative Study. Hill JA; Winniford M; Cohen MB; Van Fossen DB; Murphy MJ; Halpern EF; Ludbrook PA; Wexler L; Rudnick MR; Goldfarb S Am J Cardiol; 1993 Oct; 72(11):770-5. PubMed ID: 8213508 [TBL] [Abstract][Full Text] [Related]
3. A comparison of iohexol and diatrizoate-meglumine in children undergoing cardiac catheterization. Pelech AN; Allard SM; Hurd RT; Giddins NG; Collins GF Invest Radiol; 1991 Jul; 26(7):665-70. PubMed ID: 1885274 [TBL] [Abstract][Full Text] [Related]
4. Prospective randomized trial of iohexol 350 versus meglumine sodium diatrizoate as an oral contrast agent for abdominopelvic computed tomography. Peterson CM; Lin M; Pilgram T; Heiken JP J Comput Assist Tomogr; 2011; 35(2):202-5. PubMed ID: 21412090 [TBL] [Abstract][Full Text] [Related]
5. Nephrotoxicity of high-osmolality versus low-osmolality contrast media: randomized clinical trial. Moore RD; Steinberg EP; Powe NR; Brinker JA; Fishman EK; Graziano S; Gopalan R Radiology; 1992 Mar; 182(3):649-55. PubMed ID: 1535876 [TBL] [Abstract][Full Text] [Related]
6. Comparison of iodixanol and iohexol in patients undergoing intravenous pyelography: a prospective controlled study. Chuang FR; Chen TC; Wang IK; Chuang CH; Chang HW; Ting-Yu Chiou T; Cheng YF; Lee WC; Chen WC; Yang KD; Lee CH Ren Fail; 2009; 31(3):181-8. PubMed ID: 19288321 [TBL] [Abstract][Full Text] [Related]
7. Contrast nephrotoxicity: a randomized controlled trial of a nonionic and an ionic radiographic contrast agent. Schwab SJ; Hlatky MA; Pieper KS; Davidson CJ; Morris KG; Skelton TN; Bashore TM N Engl J Med; 1989 Jan; 320(3):149-53. PubMed ID: 2643042 [TBL] [Abstract][Full Text] [Related]
8. A randomized comparison of the nephrotoxicity of iopamidol and diatrizoate in high risk patients undergoing cardiac angiography. Taliercio CP; Vlietstra RE; Ilstrup DM; Burnett JC; Menke KK; Stensrud SL; Holmes DR J Am Coll Cardiol; 1991 Feb; 17(2):384-90. PubMed ID: 1991894 [TBL] [Abstract][Full Text] [Related]
9. [Comparative study on nephrotoxicity of ionic and non-ionic contrast agents for drip infused urography]. Sugaya K; Nishizawa O; Noto H; Suzuki T; Shimoda N; Miyagata S; Harada T; Tsuchida S Hinyokika Kiyo; 1992 Jul; 38(7):767-73. PubMed ID: 1524001 [TBL] [Abstract][Full Text] [Related]
10. Comparison of the rates of adverse drug reactions. Ionic contrast agents, ionic agents combined with steroids, and nonionic agents. Wolf GL; Mishkin MM; Roux SG; Halpern EF; Gottlieb J; Zimmerman J; Gillen J; Thellman C Invest Radiol; 1991 May; 26(5):404-10. PubMed ID: 2055736 [TBL] [Abstract][Full Text] [Related]
11. Comparison of iohexol 300 and diatrizoate meglumine 60 for body CT: image quality, adverse reactions, and aborted/repeated examinations. Bernardino ME; Fishman EK; Jeffrey RB; Brown PC AJR Am J Roentgenol; 1992 Mar; 158(3):665-7. PubMed ID: 1739017 [TBL] [Abstract][Full Text] [Related]
12. Radiocontrast nephropathy: is it dose related or not? Mekan SF; Rabbani MA; Azhar-uddin M; Ali SS J Pak Med Assoc; 2004 Jul; 54(7):372-4. PubMed ID: 15449920 [TBL] [Abstract][Full Text] [Related]
13. The use of iohexol in pediatric urography: a comparative study with meglumine diatrizoate. Bani E; Federighi F; Ghio R; Marchitiello M; Galigani P; Palla R Int J Pediatr Nephrol; 1985; 6(4):271-4. PubMed ID: 4093245 [TBL] [Abstract][Full Text] [Related]
14. A comparative study of the nephrotoxicity of iohexol, iopamidol and ioxaglate in peripheral angiography. Campbell DR; Flemming BK; Mason WF; Jackson SA; Hirsch DJ; MacDonald KJ Can Assoc Radiol J; 1990 Jun; 41(3):133-7. PubMed ID: 2354386 [TBL] [Abstract][Full Text] [Related]
15. Comparison of patient reactions and diagnostic quality for hysterosalpingography using ionic and nonionic contrast media. Chen MY; Zagoria RJ; Fayez JA; Ott DJ; Van Swearingen FL Acad Radiol; 1995 Feb; 2(2):123-7. PubMed ID: 9419535 [TBL] [Abstract][Full Text] [Related]
16. A comparison of low- with high-osmolality contrast agents in cardiac angiography. Identification of criteria for selective use. Matthai WH; Kussmaul WG; Krol J; Goin JE; Schwartz JS; Hirshfeld JW Circulation; 1994 Jan; 89(1):291-301. PubMed ID: 8281660 [TBL] [Abstract][Full Text] [Related]
17. Impact of diabetic and pre-diabetic state on development of contrast-induced nephropathy in patients with chronic kidney disease. Toprak O; Cirit M; Yesil M; Bayata S; Tanrisev M; Varol U; Ersoy R; Esi E Nephrol Dial Transplant; 2007 Mar; 22(3):819-26. PubMed ID: 17090607 [TBL] [Abstract][Full Text] [Related]
18. Nephrotoxicity of nonionic contrast media after cardiac angiography. Taliercio CP; McCallister SH; Holmes DR; Ilstrup DM; Vlietstra RE Am J Cardiol; 1989 Oct; 64(12):815-6. PubMed ID: 2801538 [No Abstract] [Full Text] [Related]
19. Renal effects and nephrotoxicity of contrast media in renal patients. Donadio C; Tramonti G; Giordani R; Lucchetti A; Calderazzi A; Ferrari P; Bianchi C Contrib Nephrol; 1993; 101():241-50. PubMed ID: 8467681 [No Abstract] [Full Text] [Related]